Page last updated: 2024-08-17

medroxyprogesterone acetate and Peripheral Vascular Diseases

medroxyprogesterone acetate has been researched along with Peripheral Vascular Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allison, M; Bonds, DE; Caralis, P; Criqui, MH; Hsia, J; Kotchen, JM; Langer, RD; Masaki, K; Phillips, LS; Resnick, HE; Rodabough, RJ	1
Beard, RW; Foong, LC; Gamble, J; Sutherland, IA	1
Applegate, WB; Carr, M; Hsia, J; Hunninghake, D; Lin, F; Simon, JA; Vogt, MT	1

Trials

2 trial(s) available for medroxyprogesterone acetate and Peripheral Vascular Diseases

Article	Year
Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation, 2004, Feb-10, Volume: 109, Issue:5 Topics: Aged; Arteries; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Peripheral Vascular Diseases; Risk Factors; Treatment Failure	2004
Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study. Circulation, 2000, Oct-31, Volume: 102, Issue:18 Topics: Aged; Arteries; Comorbidity; Coronary Disease; Drug Combinations; Estrogens; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Multivariate Analysis; Peripheral Vascular Diseases; Postmenopause; Risk Assessment; Risk Factors	2000

Article

Year

Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.

Circulation, 2004, Feb-10, Volume: 109, Issue:5

Topics: Aged; Arteries; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Peripheral Vascular Diseases; Risk Factors; Treatment Failure

2004

Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study.

Circulation, 2000, Oct-31, Volume: 102, Issue:18

Topics: Aged; Arteries; Comorbidity; Coronary Disease; Drug Combinations; Estrogens; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Multivariate Analysis; Peripheral Vascular Diseases; Postmenopause; Risk Assessment; Risk Factors

2000

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Peripheral Vascular Diseases

Article	Year
Altered peripheral vascular response of women with and without pelvic pain due to congestion. BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:2 Topics: Blood Flow Velocity; Case-Control Studies; Contraceptive Agents, Female; Female; Fertility Agents, Female; Follicular Phase; Head-Down Tilt; Heart Rate; Humans; Leuprolide; Luteal Phase; Medroxyprogesterone Acetate; Pelvic Pain; Peripheral Vascular Diseases; Postmenopause; Skin	2000

Article

Year

Altered peripheral vascular response of women with and without pelvic pain due to congestion.

BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:2

Topics: Blood Flow Velocity; Case-Control Studies; Contraceptive Agents, Female; Female; Fertility Agents, Female; Follicular Phase; Head-Down Tilt; Heart Rate; Humans; Leuprolide; Luteal Phase; Medroxyprogesterone Acetate; Pelvic Pain; Peripheral Vascular Diseases; Postmenopause; Skin

2000